BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
cell-cell adhesion
,
Influenza
,
Neuron
,
Autoimmunity
,
Doxorubicin
,
rs2476601
,
ZBTB7A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Aldesleukin
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
IL2RB
IL2RA
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
interleukin-2-mediated signaling pathway
GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP
MODULE_73
REACTOME_IL_RECEPTOR_SHC_SIGNALING
PID_IL2_STAT5_PATHWAY
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
An Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Inter…
Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a…
The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of res…
Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes …
Dantrolene sodium for the treatment of aldesleukin-induced rigors in a melanoma patient.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Aerosolized Aldesleukin in Treating Patients With Lung Metastases
Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma
Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma
Biomarkers That Predict Response to High-Dose Aldesleukin in Patients With Metastatic Kidney Cancer …
Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ